Cars.com
CARS
Teradata Corp
TDC
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
Workday
WDAY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 57.53%137.76M | 104.49%16.17M | 350.99%16.16M | 13.29%25.79M | 49.72%79.65M | 124.06%87.46M | -59.99%7.91M | 31.92%3.58M | 4,594.43%22.77M | 230.94%53.2M |
Net income from continuing operations | 73.39%101.49M | 3.62%5.3M | 362.15%17.72M | 51.65%45.49M | 68.37%32.98M | 169.39%58.53M | 874.70%5.11M | 39.27%3.83M | 80.44%30M | 550.61%19.59M |
Depreciation and amortization | 14.20%9.83M | 12.32%2.66M | 14.86%2.57M | 9.38%2.3M | 21.11%2.3M | 95.21%8.61M | 115.94%2.37M | 103.83%2.23M | 96.08%2.1M | 66.23%1.9M |
Deferred tax | -246.34%-4.35M | 11.77%-1.06M | -166.37%-450K | -217.90%-1.55M | -419.20%-1.3M | 17.10%-1.26M | -40.94%-1.2M | 337.42%678K | -252.17%-486K | 63.34%-250K |
Other non cash items | -145.22%-1.23M | 372.71%2.29M | -9,161.90%-1.9M | -1,420.45%-1.16M | -299.12%-454K | -184.09%-502K | -266.38%-839K | -96.85%21K | -74.93%88K | 219.37%228K |
Change In working capital | 443.89%7.01M | 70.55%-1.49M | 70.72%-4.51M | -128.43%-26.25M | 31.19%39.25M | -128.62%-2.04M | -126.97%-5.05M | -343.94%-15.42M | 41.37%-11.49M | 160.92%29.92M |
-Change in receivables | 131.11%728K | 185.30%1.66M | 630.20%790K | -125.91%-185K | -60.00%-1.54M | 3.90%-2.34M | -342.52%-1.95M | 87.46%-149K | 168.65%714K | 4.86%-960K |
-Change in inventory | -15.48%-15.7M | 25.67%-10.3M | 87.47%-935K | -116.40%-1.2M | -962.53%-3.27M | 27.56%-13.6M | -127.21%-13.85M | -56.14%-7.46M | 239.46%7.34M | 114.38%379K |
-Change in prepaid assets | 56.80%-1.86M | -81.80%-2.32M | 103.66%57K | 98.09%5.49M | -19.96%-5.09M | -138.57%-4.3M | -150.49%-1.28M | -238.07%-1.56M | -15.13%2.77M | 25.44%-4.24M |
-Change in payables and accrued expense | 29.66%23.25M | -23.06%8.74M | 30.27%-4.29M | -36.44%-30.33M | 40.56%49.13M | -42.96%17.93M | -53.21%11.36M | -505.60%-6.16M | -43.93%-22.23M | 65.84%34.95M |
-Change in other current assets | 36.42%6.3M | 103.66%2.34M | 43.96%1.67M | -1.90%1.14M | 0.43%1.16M | -7.81%4.62M | --1.15M | --1.16M | --1.16M | -11.09%1.15M |
-Change in other current liabilities | -31.34%-5.71M | -230.33%-1.61M | -43.77%-1.8M | 6.92%-1.16M | 16.33%-1.14M | 31.20%-4.35M | ---488K | ---1.25M | ---1.24M | 13.38%-1.37M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 57.53%137.76M | 104.49%16.17M | 350.99%16.16M | 13.29%25.79M | 49.72%79.65M | 124.06%87.46M | -59.99%7.91M | 31.92%3.58M | 4,594.43%22.77M | 230.94%53.2M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 100.97%1.35M | 217.79%36.42M | 132.26%20.45M | 84.51%-8.42M | -643.05%-47.1M | -443.02%-139.99M | -568.91%-30.92M | -280.65%-63.39M | -2,510.61%-54.35M | 458.09%8.67M |
Capital expenditure reported | -34.54%-4.73M | -22.08%-1.32M | -20.02%-1.13M | -57.70%-1.18M | -47.66%-1.11M | 30.35%-3.52M | 14.98%-1.08M | 24.90%-944K | 39.22%-747K | 42.25%-749K |
Net PPE purchase and sale | -55.64%-3.27M | -68.02%-872K | -9.14%-896K | -95.61%-847K | -99.70%-655K | 10.48%-2.1M | -66.35%-519K | -147.29%-821K | 53.04%-433K | 58.00%-328K |
Net business purchase and sale | --0 | --0 | --0 | ---- | ---- | ---23.17M | --0 | --0 | ---- | ---- |
Net investment purchase and sale | 110.46%11.51M | 233.84%40.17M | 137.59%22.55M | 79.32%-6.2M | -550.09%-45.01M | -511.18%-110.01M | -900.40%-30.01M | -307.47%-60M | -10,809.09%-30M | --10M |
Net other investing changes | -81.21%-2.15M | -325.58%-1.56M | 95.64%-71K | ---190K | -31.60%-329K | -210.73%-1.19M | --692K | ---1.63M | --0 | ---250K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 100.97%1.35M | 217.79%36.42M | 132.26%20.45M | 84.51%-8.42M | -643.05%-47.1M | -443.02%-139.99M | -568.91%-30.92M | -280.65%-63.39M | -2,510.61%-54.35M | 458.09%8.67M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -360.80%-127.3M | -2,124.61%-88.03M | -165.50%-37.56M | -362.09%-8.14M | 328.62%6.43M | 19,941.87%48.81M | -506.90%-3.96M | 104,360.00%57.34M | -416.34%-1.76M | -2,830.21%-2.81M |
Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | -1,091.44%-4.31M | --0 | --0 | -1,714.29%-1.65M | -2,672.92%-2.66M |
Net common stock issuance | -378.43%-147.59M | -4,072.34%-100.3M | -166.64%-36.93M | ---- | ---- | 8,832.45%53.01M | ---2.4M | --55.41M | ---- | ---- |
Proceeds from stock option exercised by employees | 988.09%19.01M | 12,226.32%9.37M | -32.24%996K | 1,001.49%2.21M | --6.43M | 2,229.33%1.75M | 85.37%76K | --1.47M | --201K | --0 |
Net other financing activities | 178.45%1.28M | --2.91M | ---- | ---- | ---- | -351.39%-1.63M | ---- | ---- | ---312K | ---151K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -360.80%-127.3M | -2,124.61%-88.03M | -165.50%-37.56M | -362.09%-8.14M | 328.62%6.43M | 19,941.87%48.81M | -506.90%-3.96M | 104,360.00%57.34M | -416.34%-1.76M | -2,830.21%-2.81M |
Net cash flow | ||||||||||
Beginning cash position | -10.08%38.77M | 30.23%86.08M | 26.60%86.99M | -23.98%77.62M | -10.08%38.77M | 39.58%43.11M | 135.42%66.1M | 60.61%68.71M | 129.03%102.1M | 39.58%43.11M |
Current changes in cash | 417.23%11.82M | -31.43%-35.45M | 61.55%-949K | 127.68%9.23M | -34.00%38.98M | -128.64%-3.73M | -286.22%-26.97M | 82.36%-2.47M | -3,106.44%-33.35M | 335.63%59.06M |
Effect of exchange rate changes | 62.12%-236K | 20.05%-291K | 132.64%47K | 429.27%135K | -71.62%-127K | 20.23%-623K | -165.59%-364K | 79.78%-144K | 94.58%-41K | -155.64%-74K |
End cash Position | 29.87%50.35M | 29.87%50.35M | 30.23%86.08M | 26.60%86.99M | -23.98%77.62M | -10.08%38.77M | -10.08%38.77M | 135.42%66.1M | 60.61%68.71M | 129.03%102.1M |
Free cash flow | 58.56%129.76M | 121.58%13.98M | 677.23%14.13M | 10.10%23.77M | 49.43%77.89M | 158.70%81.84M | -65.93%6.31M | 131.00%1.82M | 1,732.98%21.59M | 281.76%52.12M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |